Medical Condition News

RSS

Nuvilex to acquire live cell encapsulation technology for multiple cancer therapies

Nuvilex, Inc. announced today it has entered into discussions to acquire the next generation live cell encapsulation technology that serves as the platform for multiple cancer therapies.

15 Jun 2011

Precise method to determine age of bruises

Forensic scientists have to rely on their own subjective experience when asked to ascertain the age of contusions. Now, however, researchers in Norway have found a far more objective and precise method.

15 Jun 2011

Leukothera effectively treats psoriasis in humanized mouse xenograft transplantation model

Psoriasis is a persistent, long-lasting chronic skin disease affecting 2-3 percent of the world's population or more than 125 million individuals. For some, it is just a nuisance. For others, it is disabling.

15 Jun 2011

Hanger Orthopedic to deploy NextGen Ambulatory EHR and Practice Management

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today that Hanger Orthopedic Group, Inc. will deploy NextGen Ambulatory EHR and NextGen Practice Management.

15 Jun 2011

High FGF-23 hormone levels linked to increased risk of end-stage renal disease and death

Patients in the early stages of chronic kidney disease who had elevated levels of the endocrine hormone fibroblast growth factor 23 (that regulates phosphorus metabolism) had an associated increased risk of end-stage renal disease and death, according to a study in the June 15 issue of JAMA.

15 Jun 2011

John Theurer Cancer Center, LRF partner for Philadelphia Lymphoma Rounds program

On June 15, the Lymphoma Research Foundation (LRF), in collaboration with the John Theurer Cancer Center at Hackensack University Medical Center, will bring together lymphoma experts to discuss the latest practices in the diagnosis and management of lymphoma.

15 Jun 2011

HTX provides $750,000 funding to Profound Medical through Technology Assessment Program

HTX, a member of the Canadian Venture Capital Association, announced today it provided $750,000 in financing to Profound Medical Inc. through their Technology Assessment Program.

15 Jun 2011

ESC publishes position paper to raise the profile of vulnerable plaques

The European Society of Cardiology (ESC) Working Group of Atherosclerosis and Vascular Biology has published a position paper to raise the profile of vulnerable plaques and the need for greater use of therapies to promote plaque stabilisation.

15 Jun 2011

Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer

A type of virus known as the human reovirus possesses a remarkable trait: It can replicate inside and kill cancer cells that feature a common mutation, while leaving the body's normal cells alone.

15 Jun 2011

Researchers reveal how anti-arrhythmic drugs control irregular heartbeats

University of British Columbia researchers - using an innovative, atom-by-atom substitution method - have uncovered the mechanism by which a particular class of drugs controls irregular heartbeats.

15 Jun 2011

immatics initiates IMA901 Phase III trial in renal cell carcinoma

igoommatics biotechnologies GmbH, a biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, announced today that the first patients have been vaccinated in the IMPRINT study, a pivotal Phase III trial with IMA901, the company's lead cancer vaccine for the treatment of renal cell carcinoma.

15 Jun 2011

Meda presents new positive results from Dymista Phase-III trial on AR at EAACI 2011

Meda presents new positive results from a Phase-III clinical trial of Dymista at the annual meeting of the European Academy of Allergy and Clinical Immunology (EAACI) in Istanbul, Turkey.

15 Jun 2011

Study investigates effects of dopamine replacement therapy on cognition in patients with Parkinson's

Dopamine replacement therapy, which is used to manage motor symptoms associated with Parkinson's disease, can, at times, adversely affect cognition.

15 Jun 2011

Scientists use time-lapse technique to create lab model for ovarian cancer

Scientists at Harvard University have created a laboratory model using time-lapse video microscopic technology that allows observation of early stages of ovarian cancer metastasis.

15 Jun 2011

Bariatric surgery reduces risk of heart attack, stroke or death

Bariatric surgery can cut the incidence of heart attack, stroke or death by as much as 50 percent, according to a new study presented here at the 28th Annual Meeting of the American Society for Metabolic & Bariatric Surgery.

15 Jun 2011

Change in diet can reduce cancer risk

Eating a low-carbohydrate, high-protein diet may reduce the risk of cancer and slow the growth of tumors already present, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

15 Jun 2011

Copper induces protein misfolding, creates fibrillar plaques of Parkinson's disease

Researchers at North Carolina State University have figured out how copper induces misfolding in the protein associated with Parkinson's disease, leading to creation of the fibrillar plaques which characterize the disease.

15 Jun 2011

California adults increase fruit and vegetable consumption from 1997-2007

According to the United States Department of Health and Human Services' Healthy People 2010 objectives, adequate fruit and vegetable consumption is a national public health priority for disease prevention and maintenance of good health.

15 Jun 2011

Wnt signaling may help target hair pigmentation

A new study by researchers at NYU Langone Medical Center has shown that, for the first time, Wnt signaling, already known to control many biological processes, between hair follicles and melanocyte stem cells can dictate hair pigmentation. The study was published in the June 11, 2011 issue of the journal Cell.

15 Jun 2011

Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain

Most people think that arthritis is an inevitable part of aging. Today, Jamieson Laboratories has introduced UC-II undenatured collagen, a formulation that will turn back the clock on joint pain by naturally promoting the restoration of cartilage and inhibiting its deterioration. This new anti-aging formula taken only once daily is proven to be twice as effective as other joint remedies.

15 Jun 2011

Medical Condition News

Nuvilex to acquire live cell encapsulation technology for multiple cancer therapies

Precise method to determine age of bruises

Leukothera effectively treats psoriasis in humanized mouse xenograft transplantation model

Hanger Orthopedic to deploy NextGen Ambulatory EHR and Practice Management

High FGF-23 hormone levels linked to increased risk of end-stage renal disease and death

John Theurer Cancer Center, LRF partner for Philadelphia Lymphoma Rounds program

HTX provides $750,000 funding to Profound Medical through Technology Assessment Program

ESC publishes position paper to raise the profile of vulnerable plaques

Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer

Researchers reveal how anti-arrhythmic drugs control irregular heartbeats

immatics initiates IMA901 Phase III trial in renal cell carcinoma

Meda presents new positive results from Dymista Phase-III trial on AR at EAACI 2011

Study investigates effects of dopamine replacement therapy on cognition in patients with Parkinson's

Scientists use time-lapse technique to create lab model for ovarian cancer

Bariatric surgery reduces risk of heart attack, stroke or death

Change in diet can reduce cancer risk

Copper induces protein misfolding, creates fibrillar plaques of Parkinson's disease

California adults increase fruit and vegetable consumption from 1997-2007

Wnt signaling may help target hair pigmentation

Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Latest News